1. Home
  2. BGLC vs CAUD Comparison

BGLC vs CAUD Comparison

Compare BGLC & CAUD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BGLC
  • CAUD
  • Stock Information
  • Founded
  • BGLC N/A
  • CAUD 2019
  • Country
  • BGLC Malaysia
  • CAUD United States
  • Employees
  • BGLC 30
  • CAUD N/A
  • Industry
  • BGLC Medical Specialities
  • CAUD Finance: Consumer Services
  • Sector
  • BGLC Health Care
  • CAUD Finance
  • Exchange
  • BGLC Nasdaq
  • CAUD Nasdaq
  • Market Cap
  • BGLC 9.2M
  • CAUD 7.3M
  • IPO Year
  • BGLC N/A
  • CAUD N/A
  • Fundamental
  • Price
  • BGLC $0.51
  • CAUD $0.53
  • Analyst Decision
  • BGLC
  • CAUD
  • Analyst Count
  • BGLC 0
  • CAUD 0
  • Target Price
  • BGLC N/A
  • CAUD N/A
  • AVG Volume (30 Days)
  • BGLC N/A
  • CAUD 111.0K
  • Earning Date
  • BGLC N/A
  • CAUD 08-21-2024
  • Dividend Yield
  • BGLC N/A
  • CAUD N/A
  • EPS Growth
  • BGLC N/A
  • CAUD N/A
  • EPS
  • BGLC N/A
  • CAUD N/A
  • Revenue
  • BGLC N/A
  • CAUD $12,142,099.00
  • Revenue This Year
  • BGLC N/A
  • CAUD N/A
  • Revenue Next Year
  • BGLC N/A
  • CAUD N/A
  • P/E Ratio
  • BGLC N/A
  • CAUD N/A
  • Revenue Growth
  • BGLC N/A
  • CAUD N/A
  • 52 Week Low
  • BGLC N/A
  • CAUD $0.35
  • 52 Week High
  • BGLC N/A
  • CAUD $38.40
  • Technical
  • Relative Strength Index (RSI)
  • BGLC 54.22
  • CAUD 54.71
  • Support Level
  • BGLC $0.46
  • CAUD $0.42
  • Resistance Level
  • BGLC $0.55
  • CAUD $0.58
  • Average True Range (ATR)
  • BGLC 0.04
  • CAUD 0.06
  • MACD
  • BGLC 0.01
  • CAUD -0.00
  • Stochastic Oscillator
  • BGLC 44.29
  • CAUD 70.62

About BGLC BioNexus Gene Lab Corp Common stock

BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.

About CAUD Collective Audience Inc..

Collective Audience Inc is a provider of e-commerce and digital customer acquisition solutions by simplifying digital advertising. It provides a platform that brings you all the latest trends, news, and strategies to use from the collective intelligence of their contributors. The company's digital marketing business includes a holistic, self-serve ad tech platform. Its proprietary data-driven, AI-powered solutions allows brands and agencies to advertise across thousands of the world's leading digital and connected TV publishers.

Share on Social Networks: